Terms: = Lymphoma AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Prognosis
26 results:
1. MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8.
Mandato E; Yan Q; Ouyang J; Paczkowska J; Qin Y; Hao Y; Bojarczuk K; Hansen J; Chapuy B; Rodig SJ; Khan SJ; Redd RA; Shipp MA
Blood; 2023 Oct; 142(14):1219-1232. PubMed ID: 37467575
[TBL] [Abstract] [Full Text] [Related]
2. HSP90 inhibitor NVP-BEP800 affects stability of src kinases and growth of T-cell and B-cell acute lymphoblastic leukemias.
Mshaik R; Simonet J; Georgievski A; Jamal L; Bechoua S; Ballerini P; Bellaye PS; Mlamla Z; Pais de Barros JP; Geissler A; Francin PJ; Girodon F; Garrido C; Quéré R
Blood Cancer J; 2021 Mar; 11(3):61. PubMed ID: 33737511
[TBL] [Abstract] [Full Text] [Related]
3. Targeting critical kinases and anti-apoptotic molecules overcomes steroid resistance in MLL-rearranged leukaemia.
de Groot AP; Saito Y; Kawakami E; Hashimoto M; Aoki Y; Ono R; Ogahara I; Fujiki S; Kaneko A; Sato K; Kajita H; Watanabe T; Takagi M; Tomizawa D; Koh K; Eguchi M; Ishii E; Ohara O; Shultz LD; Mizutani S; Ishikawa F
EBioMedicine; 2021 Feb; 64():103235. PubMed ID: 33581643
[TBL] [Abstract] [Full Text] [Related]
4. Identification of the src-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.
Lantermans HC; Minderman M; Kuil A; Kersten MJ; Pals ST; Spaargaren M
Leukemia; 2021 Mar; 35(3):881-886. PubMed ID: 32591642
[TBL] [Abstract] [Full Text] [Related]
5. MLL-Rearranged Acute Lymphoblastic Leukemia.
El Chaer F; Keng M; Ballen KK
Curr Hematol Malig Rep; 2020 Apr; 15(2):83-89. PubMed ID: 32350732
[TBL] [Abstract] [Full Text] [Related]
6. Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia.
Gang EJ; Kim HN; Hsieh YT; Ruan Y; Ogana HA; Lee S; Pham J; Geng H; Park E; Klemm L; Willman CL; Carroll WL; Mittelman SD; Orgel E; Oberley MJ; Parekh C; Abdel-Azim H; Bhojwani D; Wayne AS; De Arcangelis A; Georges-Labouesse E; Wayner E; Bonig H; Minasyan A; Ten Hoeve J; Graeber TG; Müschen M; Heisterkamp N; Kim YM
Blood; 2020 Jul; 136(2):210-223. PubMed ID: 32219444
[TBL] [Abstract] [Full Text] [Related]
7. Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells.
Tabata M; Tsubaki M; Takeda T; Tateishi K; Tsurushima K; Imano M; Satou T; Ishizaka T; Nishida S
BMC Complement Med Ther; 2020 Mar; 20(1):84. PubMed ID: 32171300
[TBL] [Abstract] [Full Text] [Related]
8. Phosphorylated STAT3 expression predicts better prognosis in smoldering type of adult T-cell leukemia/lymphoma.
Morichika K; Karube K; Kayo H; Uchino S; Nishi Y; Nakachi S; Okamoto S; Morishima S; Ohshiro K; Nakazato I; Fukushima T; Masuzaki H
Cancer Sci; 2019 Sep; 110(9):2982-2991. PubMed ID: 31237072
[TBL] [Abstract] [Full Text] [Related]
9. JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type.
Liu J; Liang L; Li D; Nong L; Zheng Y; Huang S; Zhang B; Li T
Oncol Rep; 2019 Jun; 41(6):3219-3232. PubMed ID: 31002364
[TBL] [Abstract] [Full Text] [Related]
10. Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell lymphoma.
Cann ML; Herring LE; Haar LL; Gilbert TSK; Goldfarb D; Richards KL; Graves LM; Lawrence DS
J Proteome Res; 2019 Jan; 18(1):522-534. PubMed ID: 30540191
[TBL] [Abstract] [Full Text] [Related]
11. Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function.
Damele L; Montaldo E; Moretta L; Vitale C; Mingari MC
Front Immunol; 2018; 9():2433. PubMed ID: 30405627
[TBL] [Abstract] [Full Text] [Related]
12. STAT3 mediates multidrug resistance of Burkitt lymphoma cells by promoting antioxidant feedback.
Zeng R; Tang Y; Zhou H; Liu Y; Huang J; Li L; Liu W; Feng Y; Zhou Y; Chen T; Zhang L; Zhong M
Biochem Biophys Res Commun; 2017 Jun; 488(1):182-188. PubMed ID: 28483518
[TBL] [Abstract] [Full Text] [Related]
13. Sam68 regulates cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) via the AKT pathway in non-Hodgkin's lymphoma.
Wu Y; Xu X; Miao X; Zhu X; Yin H; He Y; Li C; Liu Y; Chen Y; Lu X; Wang Y; He S
Cell Prolif; 2015 Dec; 48(6):682-90. PubMed ID: 26478515
[TBL] [Abstract] [Full Text] [Related]
14. The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis.
Zhang L; Teng Y; Fan Y; Wang Y; Li W; Shi J; Ma Y; Li C; Shi X; Qu X; Liu Y
Oncotarget; 2015 Sep; 6(26):22918-33. PubMed ID: 26087197
[TBL] [Abstract] [Full Text] [Related]
15. The differences in clinicopathological features and prognosis among the subtypes of signet ring cell, mucinous, papillary, and lymphoepithelioma-like carcinoma in advanced gastric cancer.
Kim KH; Kim MC; Jung GJ; Kim SJ
Hepatogastroenterology; 2014 Oct; 61(135):2149-55. PubMed ID: 25713922
[TBL] [Abstract] [Full Text] [Related]
16. Novel adaptor protein Shf interacts with ALK receptor and negatively regulates its downstream signals in neuroblastoma.
Takagi D; Tatsumi Y; Yokochi T; Takatori A; Ohira M; Kamijo T; Kondo S; Fujii Y; Nakagawara A
Cancer Sci; 2013 May; 104(5):563-72. PubMed ID: 23360421
[TBL] [Abstract] [Full Text] [Related]
17. src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Spijkers-Hagelstein JA; Mimoso Pinhanços S; Schneider P; Pieters R; Stam RW
Leukemia; 2013 Apr; 27(5):1063-71. PubMed ID: 23334362
[TBL] [Abstract] [Full Text] [Related]
18. Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Spijkers-Hagelstein JA; Schneider P; Hulleman E; de Boer J; Williams O; Pieters R; Stam RW
Leukemia; 2012 Jun; 26(6):1255-65. PubMed ID: 22282267
[TBL] [Abstract] [Full Text] [Related]
19. Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia.
Yamazaki H; Xu CW; Naito M; Nishida H; Okamoto T; Ghani FI; Iwata S; Inukai T; Sugita K; Morimoto C
Biochem Biophys Res Commun; 2011 May; 409(1):14-21. PubMed ID: 21549094
[TBL] [Abstract] [Full Text] [Related]
20. Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations.
Kfir-Erenfeld S; Sionov RV; Spokoini R; Cohen O; Yefenof E
Leuk Lymphoma; 2010 Nov; 51(11):1968-2005. PubMed ID: 20849387
[TBL] [Abstract] [Full Text] [Related]
[Next]
